Oct 06, 2025 • Zacks Commentary
BULLISH
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Oct 06, 2025 • Benzinga
SOMEWHAT-BULLISH
Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors - Maze Therapeutics ( NASDAQ:MAZE )
SOUTH SAN FRANCISCO, Calif., Oct. 06, 2025 ( GLOBE NEWSWIRE ) -- Maze Therapeutics, Inc. ( NASDAQ:MAZE ) , a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced the appointment of Hervé Hoppenot ...
Oct 06, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors
SOUTH SAN FRANCISCO, Calif., Oct. 06, 2025 ( GLOBE NEWSWIRE ) -- Maze Therapeutics, Inc. ( Nasdaq: MAZE ) , a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced the appointment of Hervé Hoppenot ...
Oct 03, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Is Invesco Biotechnology & Genome ETF ( PBE ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Sep 30, 2025 • Zacks Commentary
BULLISH
INCY vs. ARGX: Which Stock Is the Better Value Option?
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte ( INCY Quick QuoteINCY - ) and argenex SE ( ARGX Quick QuoteARGX - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
Sep 28, 2025 • Business Insider
SOMEWHAT-BULLISH
China Medical System ( 867.HK; 8A8.SG ) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
China Medical System (867.HK. 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication ...